首页|期刊导航|中国中西医结合杂志|滋水涵木利胆方改善原发性胆汁性胆管炎小鼠模型肝内胆管上皮细胞间质化的分子机制研究

滋水涵木利胆方改善原发性胆汁性胆管炎小鼠模型肝内胆管上皮细胞间质化的分子机制研究OA

Molecular Mechanism Study of Zishui Hanmu Lidan Decoction for Improving IBEC-EMT in a Mouse Model of Primary Biliary Cholangitis

中文摘要英文摘要

目的 探究滋水涵木利胆方(ZHLD)改善原发性胆汁性胆管炎(PBC)小鼠模型肝内胆管上皮细胞间质化(IBEC-EMT)分子作用机制.方法 将60只C57BL/6雌性小鼠随机分为空白组、PBC模型组(PBC组)、熊去氧胆酸组(UDCA组)、低剂量组(L-ZHLD组)、中剂量组(M-ZHLD组)、高剂量组(H-ZHLD组),每组10只.除空白组外,其余5组构建PBC小鼠模型.造模同时,PBC组每日予等剂量生理盐水灌胃;UDCA组每日予熊去氧胆酸胶囊0.1 g/kg灌胃;L、M、H-ZHLD组每日分别予ZHLD颗粒1、2、4 g/kg稀释后灌胃.8周后收集小鼠血清及肝组织.ELISA检测血清抗线粒体抗体M2型(AMA-M2)、抗核抗体(ANA);HE观察肝组织病理;免疫组化检测细胞角质蛋白(CK)7、CK19及E-钙黏蛋白(E-Cadherin)、波形蛋白(Vimentin)表达;Western Blot检测通路P38-丝裂原活化蛋白激酶(P38-MAPK)、细胞外信号调节激酶 1/2(ERK1/2)、c-Jun 氨基末端激酶(JNK)、p-ERK1/2、p-P38MAPK、p-JNK及胆管上皮间质化蛋白E-Cadherin、Vimentin表达;采用实时定量反转录聚合酶链式反应(RT-PCR)检测E-Cadherin、Vimentin mRNA定量.结果 与空白组比较,PBC组可见汇管区小胆管增生,淋巴细胞、单核细胞浸润,CK7、CK19、p-P38MAPK、p-ERK1/2、p-JNK蛋白表达增加,Vimentind蛋白及基因表达均增加,而E-Cadherin蛋白及基因表达均减少(P<0.01).与PBC组比较,UDCA组及L、M、H-ZHLD组汇管区淋巴细胞浸润均减少,CK7、CK19、p-ERK1/2蛋白表达减少,Vimentind蛋白及基因表达均减少,E-Cadherin 蛋白及基因表达均增加(P<0.05,P<0.01);M、H-ZHLD 组 p-P38MAPK、p-JNK 蛋白表达减少(P<0.01).与UDCA组比较,L、M、H-ZHLD组汇管区淋巴细胞浸润均减少,CK7、p-ERK1/2蛋白表达减少(P<0.01);M、H-ZHLD组CK19、p-P38MAPK、p-JNK蛋白表达减少,Vimentin蛋白及基因表达均减少,E-Cadherin蛋白及基因表达均增加(P<0.01).与L-ZHLD组比较,M、H-ZHLD组CK7、CK19、p-P38MAPK、p-ERK1/2、p-JNK 蛋白表达减少(P<0.01);Vimentin 蛋白及基因表达减少(P<0.01),E-Cadherin蛋白及基因表达增加(P<0.01).结论 ZHLD可能通过下调通路P38-MAPK、ERK1/2、JNK磷酸化水平,减少CK7、CK19、Vimentin表达,上调E-Cadherin表达,减少胆管增生,进而调控PBC小鼠模型IBEC-EMT.在ZHLD低、中、高剂量中,中剂量为改善PBC小鼠IBEC-EMT最佳治疗剂量.

Objective To study the molecular mechanism of Zishui Hanmu Lidan Decoction(ZHLD)in improving epithelial mesenchymal transition of intrahepatic bile duct epithelial cells(IBEC-EMT)in a mouse model of primary biliary cholangitis(PBC).Methods Sixty C57BL/6 female mice were randomly divided into blank group,PBC model group(PBC group),ursodeoxycholic acid group(UDCA group),low dose group(L-ZHLD group),medium dose group(M-ZHLD group)and high dose group(H-ZHLD group),10 in each group.Except for the blank group,the other five groups established a PBC mouse model.At the same time,the same daily dose of normal saline was given to the PBC group by gastrogavage.UDCA group was given ursodeoxycholic acid capsule at 0.1 g/(kg·d)by gastrogavage.The L-ZHLD,M-ZHLD,and H-ZHLD groups were given ZHLD granule at 1,2,and 4 g/(kg·d)by gastrogavage after dilution.Serum and liver tissues were collected after 8 weeks.The expressions of serum antibodies anti-mitoehondrial M2 antibodies(AMA-M2)and anti-nuclear antibody(ANA)were detected by ELISA.HE staining was used to observe the pathological changes of liver tissue.Immunohistochemical staining was used to detect the expressions of cytokeratin(CK)7,CK19,Vimentin,and E-cadherin in bile duct epithelial cells.Western Blot was used to detect the expressions of p-ERK1/2,p-P38(MAPK),p-JNK,E-cadherin,and Vimentin in bile duct epithelial mesenchymal proteins.RT-PCR was used to detect the mRNA quantification of E-cadherin and Vimentin.Results Compared with the blank group,the PBC group showed proliferation of small bile ducts in the portal area,infiltration of lymphocytes and monocytes,increased expressions of CK7,CK19,p-P38MAPK,p-ERK1/2,and p-JNK proteins,increased protein and gene expressions of Vimentind,and decreased protein and gene expressions of E-Cadherin(P<0.01).Compared with the PBC group,the infiltration of lymphocytes in the portal area decreased in the UDCA group,L,M,and H-ZHLD groups,and the expressions of CK7,CK19,and p-ERK1/2 proteins decreased.Vimentind protein and gene expressions decreased,while E-Cadherin protein and gene expressions increased(P<0.05,P<0.01).The expressions of p-P38MAPK and p-JNK proteins decreased in the M and H-ZHLD groups(P<0.01).Compared with the UDCA group,the infiltration of lymphocytes in the portal area was reduced in the L-,M-,and H-ZHLD groups,CK7 and p-ERK1/2 protein expression were also reduced(P<0.01).The expressions of CK19,p-P38MAPK,and p-JNK proteins decreased in the M-and H-ZHLD groups,while the protein and gene expressions of Vimentin decreased.The protein and gene expressions of E-Cadherin increased(P<0.01).Compared with the L-ZHLD group,CK7,CK19,p-P38MAPK,p-JNK and p-ERK1/2 protein expression were reduced in the M-and H-ZHLD groups(P<0.01);The protein and gene expressions of Vimentin decreased(P<0.01).The protein and gene expressions of E-Cadherin increased(P<0.01).Conclusions ZHLD reduced the expressions of CK7,CK19 and Vimentin,up-regulated the expression of E-Cadherin,and reduced bile duct hyperplasia possibly by down-regulating the phosphorylation levels of P38-MAPK,ERK1/2,and JNK pathways,thereby regulating the IBEC-EMT of the PBC mouse model.Among the low,medium,and high doses of ZHLD,the medium dose was the best therapeutic dose to ameliorate the IBEC-EMT of PBC mouse model.

黄祎;赵容;谭梅傲;李麟;万颖;饶春燕;刘姝婉;刘华宝

重庆市中医院肝病科(重庆 610075)||重庆中医药学院中医学院(重庆 402760)重庆市中医院肝病科(重庆 610075)重庆市中医院肝病科(重庆 610075)重庆市中医院肝病科(重庆 610075)重庆市中医院肝病科(重庆 610075)重庆市中医院肝病科(重庆 610075)重庆市中医院肝病科(重庆 610075)重庆市中医院肝病科(重庆 610075)||重庆中医药学院中医学院(重庆 402760)

原发性胆汁性胆管炎滋水涵木利胆方肝内胆管上皮细胞间质化丝裂原活化蛋白激酶信号通路中药复方

primary biliary cholangitisZishui Hanmu Lidan Decoctionepithelial mesenchymal transition of intrahepatic bile duct epithelial cellMAPK signal pathwayChinese herbal compound

《中国中西医结合杂志》 2026 (2)

200-207,8

重庆市自然科学基金面上项目(No.cstc2021jcyj-msxmX0390)全国名中医传承工作室建设项目(No.国中医药办人教函[2022]245号)

10.7661/j.cjim.20250516.262

评论